Infection with the helicobacter pylori bacteria, usually referred to as H. pylori, is common, affecting almost half of all people in the United States at some point in their lifetime. In most cases, ...
Rising resistance to clarithromycin and levofloxacin necessitates avoiding these in treatment regimens without susceptibility testing. Bismuth quadruple therapy is recommended for treatment-naive ...
In a phase III trial from China, triple therapy containing rifasutenizol-- a novel antimicrobial designed for Helicobacter pylori -- proved noninferior to bismuth plus clarithromycin-based triple ...
Helicobacter pylori (H. pylori) bacteria are commonly present in the stomach lining. In some cases, they can cause peptic and duodenal ulcers. Natural treatments — such as honey, aloe vera, and ...
Please provide your email address to receive an email when new articles are posted on . Concomitant and bismuth quadruple therapies had success rates of nearly 90% for initial treatment of H. pylori.
45% of patients infected with H. pylori do not receive proper treatment, 1st of its kind study finds
It is something that nearly 36 percent of U.S. adults are infected with at some point. Normally, H. pylori can be treated with antibiotics early on, but when left untreated can lead to detrimental ...
Potent Tool: Helicobacter pylori Treatment to Reduce the Risk of Both Gastric and Colorectal Cancers
For decades there has been a heated yet still unresolved debate on the benefits and harms of eradication treatment for H. pylori, a common bacterium that causes gastric cancer in a small percentage of ...
Globally, stomach cancer is on the rise in young people, but new research shows that three-quarters of future cases could be prevented by screening for and treating a common bacterial infection: ...
The American Journal of Gastroenterology has published a new guideline on the treatment of Helicobacter pylori (H. pylori) infection. The number one recommendation for treatment-naive patients is ...
Bismuth quadruple therapy for 14 days is preferred regimen for treatment-naive patients when antibiotic susceptibility is unknown. William D. Chey, MD, from Michigan Medicine in Ann Arbor, and ...
Several Twitter users on Thursday, November 25, took to the micro-blogging site to narrate their experiences with bacteria Helicobacter pylori (H. Pylori). The users observed that H. Pylori seems to ...
An invitation to undergo screening for Helicobacter pylori stool antigen did not reduce rates of gastric cancer incidence or mortality, according to results from a Taiwanese randomized trial. Among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback